CD28 and ovarian carcinoma: Whereas a study comparing chimeric receptors for NK cells with NKG2D ectodomain combined with CD3ζ, CD28-CD3ζ or 4-1BB-CD28-CD3ζ showed higher cytotoxicity against ovarian cancer with the construct containing only CD3ζ [116].